Joseph Miller
Director of Finance/CFO bei AURINIA PHARMACEUTICALS INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Joseph M.
Miller is currently the Chief Financial Officer at Aurinia Pharmaceuticals, Inc. He previously worked as the Senior Director-Accounting at Qiagen Genomics, Inc. from 2006 to 2015.
From 2018 to 2022, he served as the Director at Avalo Therapeutics, Inc. Prior to that, he was the Vice President-Finance at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Mr. Miller also held the position of Chief Financial Officer & Vice President-Finance at Eppendorf-5 Prime, Inc. from 2002 to 2006.
He obtained his undergraduate degree from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2024 | 495 928 ( 0,34% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Joseph Miller
| Unternehmen | Position | Beginn |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director of Finance/CFO | 27.04.2020 |
Ehemalige bekannte Positionen von Joseph Miller
| Unternehmen | Position | Ende |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 24.04.2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.04.2018 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 01.01.2015 |
| Eppendorf-5 Prime, Inc. | Director of Finance/CFO | 01.01.2006 |
Ausbildung von Joseph Miller
| Villanova University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
| Eppendorf-5 Prime, Inc. |
